 | |
| Clinical data | |
|---|---|
| Routes of administration | Oral |
| ATC code |
|
| Legal status | |
| Legal status |
|
| Identifiers | |
| |
| CAS Number | |
| PubChemCID | |
| ChemSpider | |
| UNII | |
| CompTox Dashboard(EPA) | |
| Chemical and physical data | |
| Formula | C20H23N3 |
| Molar mass | 305.425 g·mol−1 |
| 3D model (JSmol) | |
| |
Fezolamine (Win-41,528-2) is adrug which was investigated bySterling Drug as anantidepressant in the 1980s.[1][2] TheisomericN,N-dimethyl-4,5-diphenyl-1H-pyrazole-1-propanamine was completely inactive in the primary antidepressant screens.
It acts as aserotonin,norepinephrine, anddopaminereuptake inhibitor, with 3- to 4-fold preference for the formerneurotransmitter.[3] It was found to be effective and well tolerated inclinical trials but was never marketed.[4]
Changing the sidechain leads to an agent calledipazilide.
